Biocon Limited reported unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, on consolidated basis, the company announced net sales or income from operations of INR 10,293 million compared to INR 7,962 million a year ago. Profit from operations before other income and finance costs and exceptional items were INR 2,058 million compared to INR 1,209 million a year ago. Profit from ordinary activities before tax was INR 2,444 million compared to INR 1,410 million a year ago. Net profit for the period was INR 1,900 million or INR 8.65 per basic and diluted share compared to INR 1,192 million or INR 5.3 per basic and diluted share a year ago. EBITDA was INR 3,220 million compared to INR 2,090 million for the same period a year ago. For the nine months, on consolidated basis, the company announced net sales or income from operations, net of excise duty of INR 29,513 million compared to INR 23,463 million a year ago. Profit from operations before other income and finance costs and exceptional items were INR 5,745 million compared to INR 3,793 million a year ago. Profit from ordinary activities before tax was INR 6,802 million compared to INR 3,259 million a year ago. Net profit for the period was INR 5,289 million or INR 24.55 per diluted share compared to INR 2,383 million or INR 11.06 per diluted share a year ago. EBITDA was INR 8,550 million compared to INR 6,670 million for the same period a year ago. For the quarter, on standalone basis, the company announced sales or income from operations of INR 5,932 million compared to INR 4,976 million a year ago. Profit from operations before other income and finance costs and exceptional items were INR 1,148 million compared to INR 449 million a year ago. Profit from ordinary activities before tax was INR 1,472 million compared to INR 749 million a year ago. Net profit for the period was INR 1,041 million or INR 5.26 per diluted share compared to INR 638 million or INR 3.25 per diluted share a year ago. For the nine months, on standalone basis, the company announced net sales or income from operations of INR 18,324 million compared to INR 15,476 million a year ago. Profit from operations before other income and finance costs and exceptional items were INR 3,519 million compared to INR 2,106 million a year ago. Profit from ordinary activities before tax was INR 4,371 million compared to INR 4,034 million a year ago. Net profit for the period was INR 3,155 million or INR 15.98 per diluted share compared to INR 2,398 million or INR 12.20 per diluted share a year ago.